Platelets and infection - An emerging role of platelets in viral infection

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Assinger, Alice ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immune response; Platelets; Thrombocytopenia; Thrombosis; Viruses

Indexed keywords

2', 5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; APRIL PROTEIN; BETA INTERFERON; C TYPE LECTIN DOMAIN FAMILY 2; CD209 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FC RECEPTOR II; IMMUNOGLOBULIN G; INTERLEUKIN 6; LECTIN; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOPOIETIN; THROMBOXANE A2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BLEEDING; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOMEGALOVIRUS INFECTION; DEEP VEIN THROMBOSIS; ENCEPHALOMYOCARDITIS VIRUS; HEPATITIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS; MEGAKARYOCYTE; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; REVIEW; RISK ASSESSMENT; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 84919774344     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00649     Document Type: Review

References (128)

1. Grigorian M, Hartenstein V. Hematopoiesis and hematopoietic organs in arthropods. Dev Genes Evol (2013) 223:103-15. doi: 10.1007/s00427-012-0428-2
2. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost (2003) 1:1897-905. doi:10.1046/j.1538-7836.2003.00304.x
3. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol (2013) 13:34-45. doi:10.1038/nri3345
4. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 100:27-40. doi:10.1161/01.RES.0000252802.25497.b7
5. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 123:2759-67. doi:10.1182/blood-2013-11-462432
6. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11:264-74. doi:10.1038/nri2956
7. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol (2004) 25:489-95. doi:10.1016/j.it.2004.07.003
8. Ribatti D, Crivellato E. Giulio Bizzozero and the discovery of platelets. Leuk Res (2007) 31:1339-41. doi:10.1016/j.leukres.2007.02.008
9. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation (1992) 86:III74-85.
10. Karshovska E, Weber C, von Hundelshausen P. Platelet chemokines in health and disease. Thromb Haemost (2013) 110:894-902. doi:10.1160/TH13-04-0341
11. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 112:1506-19. doi:10.1161/CIRCRESAHA.113.300512
12. Langer HF, Weber C, Gawaz M. The platelet - thrombosis and beyond. Thromb Haemost (2013) 110:857-8. doi:10.1160/TH13-09-0805
13. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer (2011) 11:123-34. doi:10.1038/nrc3004
14. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest (2005) 115:3348-54. doi:10.1172/JCI26891
15. Kuter DJ. Milestones in understanding platelet production: a historical overview. Br J Haematol (2014) 165:248-58. doi:10.1111/bjh.12781
16. de Graaf CA, Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle (2011) 10:1582-9. doi:10.4161/cc.10.10.15619
17. Metcalf Pate KA, Lyons CE, Dorsey JL, Queen SE, Adams RJ, Morrell CN, et al. TGFbeta-mediated downregulation of thrombopoietin is associated with platelet decline in asymptomatic SIV infection. J Acquir Immune Defic Syndr (2014) 65:510-6. doi:10.1097/QAI.0000000000000048
18. Isomura H, Yoshida M, Namba H, Fujiwara N, Ohuchi R, Uno F, et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. J Gen Virol (2000) 81:663-73. doi:10.1002/(SICI)1096-9071(199708)52:4<406::AID-JMV11>3.0.CO;2-E
19. Gonelli A, Mirandola P, Grill V, Secchiero P, Zauli G. Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cells. Haematologica (2002) 87:1223-5.
20. Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol (2008) 48:1000-7. doi:10.1016/j.jhep.2008.03.009
21. Kolb-Maurer A, Goebel W. Susceptibility of hematopoietic stem cells to pathogens: role in virus/bacteria tropism and pathogenesis. FEMS Microbiol Lett (2003) 226:203-7. doi:10.1016/S0378-1097(03)00643-8
22. Chelucci C, Federico M, Guerriero R, Mattia G, Casella I, Pelosi E, et al. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood (1998) 91:1225-34.
23. Li X, Jeffers LJ, Garon C, Fischer ER, Scheffel J, Moore B, et al. Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line. J Viral Hepat (1999) 6:107-14. doi:10.1046/j.1365-2893.1999.00140.x
24. Crapnell K, Zanjani ED, Chaudhuri A, Ascensao JL, St Jeor S, Maciejewski JP. In vitro infection of megakaryocytes and their precursors by human cytomegalovirus. Blood (2000) 95:487-93.
25. Flaujac C, Boukour S, Cramer-Borde E. Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci (2010) 67:545-56. doi:10.1007/s00018-009-0209-x
26. Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology (2005) 10:101-5. doi:10.1080/10245330400026170
27. Lutteke N, Raftery MJ, Lalwani P, Lee MH, Giese T, Voigt S, et al. Switch to high-level virus replication and HLA class I upregulation in differentiating megakaryocytic cells after infection with pathogenic hantavirus. Virology (2010) 405:70-80. doi:10.1016/j.virol.2010.05.028
28. Passos AM, Treitinger A, Spada C. An overview of the mechanisms of HIV-related thrombocytopenia. Acta Haematol (2010) 124:13-8. doi:10.1159/000313782
29. Carballal G, Cossio PM, Laguens RP, Ponzinibbio C, Oubina JR, Meckert PC, et al. Junin virus infection of guinea pigs: immunohistochemical and ultrastructural studies of hemopoietic tissue. J Infect Dis (1981) 143:7-14. doi:10.1093/infdis/143.1.7
30. Gibellini D, Clo A, Morini S, Miserocchi A, Ponti C, Re MC. Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol (2013) 2:91-101. doi:10.5501/wjv.v2.i2.91
31. Speth C, Loffler J, Krappmann S, Lass-Florl C, Rambach G. Platelets as immune cells in infectious diseases. Future Microbiol (2013) 8:1431-51. doi:10.2217/fmb.13.104
32. Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol (2014) 34:801-9. doi:10.1161/ATVBAHA.114.303287
33. Koupenova M, Vitseva O, MacKay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood (2014) 124:791-802. doi:10.1182/blood-2013-11-536003
34. Coulson BS, Londrigan SL, Lee DJ. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A (1997) 94:5389-94. doi:10.1073/pnas.94.10.5389
35. Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol (2001) 256:91-115. doi:10.1007/978-3-642-56753-7_6
36. Gupalo E, Kuk C, Qadura M, Buriachkovskaia L, Othman M. Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors. Platelets (2013) 24:383-91. doi:10.3109/09537104.2012.703792
37. Gavrilovskaya IN, Gorbunova EE, Mackow ER. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol (2010) 84:4832-9. doi:10.1128/JVI.02405-09
38. Goeijenbier M, van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, et al. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol (2012) 84:1680-96. doi:10.1002/jmv.23354
39. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 112:3011-25. doi:10.1182/blood-2008-06-077891
40. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med (2008) 14:325-30. doi:10.1038/nm1722
41. Kahner BN, Kato H, Banno A, Ginsberg MH, Shattil SJ, Ye F. Kindlins, integrin activation and the regulation of talin recruitment to alphaIIbbeta3. PLoS One (2012) 7:e34056. doi:10.1371/journal.pone.0034056
42. Gong H, Shen B, Flevaris P, Chow C, Lam SC, Voyno-Yasenetskaya TA, et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin "outside-in" signaling. Science (2010) 327:340-3. doi:10.1126/science.1174779
43. Nunez D, Charriaut-Marlangue C, Barel M, Benveniste J, Frade R. Activation of human platelets through gp140, the C3d/EBV receptor (CR2). Eur J Immunol (1987) 17:515-20. doi:10.1002/eji.1830170413
44. Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol (2006) 80:8951-60. doi:10.1128/JVI.00136-06
45. Othman M, Labelle A, Mazzetti I, Elbatarny HS, Lillicrap D. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood (2007) 109:2832-9. doi:10.1182/blood-2006-06-032524
46. Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol (2006) 87:2243-51. doi:10.1099/vir.0.81826-0
47. Maugeri N, Cattaneo M, Rovere-Querini P, Manfredi AA. Platelet clearance by circulating leukocytes: a rare event or a determinant of the "immune continuum"? Platelets (2014) 25:224-5. doi:10.3109/09537104.2012.763116
48. Grozovsky R, Hoffmeister KM, Falet H. Novel clearance mechanisms of platelets. Curr Opin Hematol (2010) 17:585-9. doi:10.1097/MOH.0b013e32833e7561
49. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci (2010) 67:525-44. doi:10.1007/s00018-009-0210-4
50. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest (2002) 32:759-66. doi:10.1046/j.1365-2362.2002.01041.x
51. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis (2014) 8:e2858. doi:10.1371/journal.pntd.0002858
52. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, et al. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis (2012) 205:1321-9. doi:10.1093/infdis/jis180
53. Antoniak S, Mackman N. Multiple roles of the coagulation protease cascade during virus infection. Blood (2014) 123:2605-13. doi:10.1182/blood-2013-09-526277
54. Anderson CL, Chacko GW, Osborne JM, Brandt JT. The Fc receptor for immunoglobulin G (Fc gamma RII) on human platelets. Semin Thromb Hemost (1995) 21:1-9. doi:10.1055/s-2007-1000374
55. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost (2011) 9:1097-107. doi:10.1111/j.1538-7836.2011.04264.x
56. Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, et al. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood (2014) 123:3166-74. doi:10.1182/blood-2013-11-540526
57. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest (1966) 45:645-57. doi:10.1172/JCI105380
58. Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood (2009) 113:4086-93. doi:10.1182/blood-2008-09-181073
59. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther (2007) 26(Suppl 1):13-9. doi:10.1111/j.1365-2036.2007.03512.x
60. McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med (2007) 357:2227-36. doi:10.1056/NEJMoa073255
61. Louache F, Bettaieb A, Henri A, Oksenhendler E, Farcet JP, Bierling P, et al. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood (1991) 78:1697-705.
62. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost (2013) 11:951-62. doi:10.1111/jth.12178
63. Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol (2014) 193:1864-72. doi:10.4049/jimmunol.1400091
64. Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, et al. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost (2007) 5:2291-9. doi:10.1111/j.1538-7836.2007.02754.x
65. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 122:3405-14. doi:10.1182/blood-2013-05-504449
66. Chuansumrit A, Chaiyaratana W. Hemostatic derangement in dengue hemorrhagic fever. Thromb Res (2014) 133:10-6. doi:10.1016/j.thromres.2013.09.028
67. Nascimento EJ, Hottz ED, Garcia-Bates TM, Bozza F, Marques ET Jr, Barratt-Boyes SM. Emerging concepts in dengue pathogenesis: interplay between plasmablasts, platelets, and complement in triggering vasculopathy. Crit Rev Immunol (2014) 34:227-40. doi:10.1615/CritRevImmunol.2014010212
68. Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, Chisari FV, et al. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A (2008) 105:629-34. doi:10.1073/pnas.0711200105
69. Pozner RG, Ure AE, Jaquenod de Giusti C, D'Atri LP, Italiano JE, Torres O, et al. Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling. PLoS Pathog (2010) 6:e1000847. doi:10.1371/journal.ppat.1000847
70. Wang Q, Miyakawa Y, Fox N, Kaushansky K. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood (2000) 96:2093-9.
71. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, et al. Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood (2009) 114:1645-54. doi:10.1182/blood-2009-01-199414
72. Terada H, Baldini M, Ebbe S, MadoffMA. Interaction of influenza virus with blood platelets. Blood (1966) 28:213-28.
73. Stenberg PE, Levin J, Baker G, Mok Y, Corash L. Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis. J Cell Physiol (1991) 147:7-16. doi:10.1002/jcp.1041470103
74. Turpie AG, Chernesky MA, Larke RP, Packham MA, Mustard JF. Effect of Newcastle disease virus on human or rabbit platelets. Aggregation and loss of constituents. Lab Invest (1973) 28:575-83.
75. Srivastava A, Bruno E, Briddell R, Cooper R, Srivastava C, van Besien K, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood (1990) 76:1997-2004.
76. Metcalf Pate KA, Lyons CE, Dorsey JL, Shirk EN, Queen SE, Adams RJ, et al. Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis (2013) 208:874-83. doi:10.1093/infdis/jit278
77. Singh MV, Davidson DC, Kiebala M, Maggirwar SB. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods (2012) 181:170-6. doi:10.1016/j.jviromet.2012.02.005
78. La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol (1995) 8:249-70. doi:10.1016/S0950-3536(05)80240-9
79. Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol (2014) 12:426-37. doi:10.1038/nrmicro3269
80. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis (1997) 25:951-68. doi:10.1086/516120
81. Auerbach DJ, Lin Y, Miao H, Cimbro R, Difiore MJ, Gianolini ME, et al. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Proc Natl Acad Sci U S A (2012) 109:9569-74. doi:10.1073/pnas.1207314109
82. Solomon Tsegaye T, Gnirss K, Rahe-Meyer N, Kiene M, Kramer-Kuhl A, Behrens G, et al. Platelet activation suppresses HIV-1 infection of T cells. Retrovirology (2013) 10:48. doi:10.1186/1742-4690-10-48
83. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol (1995) 107:541-6. doi:10.1159/000237097
84. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 270:1811-5. doi:10.1126/science.270.5243.1811
85. Cognasse F, Hamzeh-Cognasse H, Berthet J, Damien P, Lucht F, Pozzetto B, et al. Altered release of regulated upon activation, normal T-cell expressed and secreted protein from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides. AIDS (2009) 23:2057-9. doi:10.1097/QAD.0b013e328330da65
86. Melchjorsen J, Sorensen LN, Paludan SR. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J Leukoc Biol (2003) 74:331-43. doi:10.1189/jlb.1102577
87. Culley FJ, Pennycook AM, Tregoning JS, Dodd JS, Walzl G, Wells TN, et al. Role of CCL5 (RANTES) in viral lung disease. J Virol (2006) 80:8151-7. doi:10.1128/JVI.00496-06
88. Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol (2004) 76:886-95. doi:10.1189/jlb.1203644
89. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med (2005) 11:1180-7. doi:10.1038/nm1303
90. Katsounas A, Schlaak JF, Lempicki RA. CCL5: a double-edged sword in host defense against the hepatitis C virus. Int Rev Immunol (2011) 30:366-78. doi:10.3109/08830185.2011.593105
91. Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol (2013) 425:4965-80. doi:10.1016/j.jmb.2013.09.038
92. Mohan KV, Rao SS, Atreya CD. Antiviral activity of selected antimicrobial peptides against vaccinia virus. Antiviral Res (2010) 86:306-11. doi:10.1016/j.antiviral.2010.03.012
93. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science (2006) 312:104-7. doi:10.1126/science.1123842
94. Starlinger P, Assinger A, Haegele S, Wanek D, Zikeli S, Schauer D, et al. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. Hepatology (2014) 60:257-66. doi:10.1002/hep.26950
95. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood (2007) 109:3139-46. doi:10.1182/blood-2006-10-052787
96. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost (2005) 3:1590-6. doi:10.1111/j.1538-7836.2005.01373.x
97. Langer HF, Daub K, Braun G, Schonberger T, May AE, Schaller M, et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol (2007) 27:1463-70. doi:10.1161/ATVBAHA.107.141515
98. Hagihara M, Higuchi A, Tamura N, Ueda Y, Hirabayashi K, Ikeda Y, et al. Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro. J Immunol (2004) 172:5297-303. doi:10.4049/jimmunol.172.9.5297
99. Elzey BD, Sprague DL, RatliffTL. The emerging role of platelets in adaptive immunity. Cell Immunol (2005) 238:1-9. doi:10.1016/j.cellimm.2005.12.005
100. Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol (2008) 83:1069-78. doi:10.1189/jlb.0907615
101. Gerdes N, Zhu L, Ersoy M, Hermansson A, Hjemdahl P, Hu H, et al. Platelets regulate CD4(+) T-cell differentiation via multiple chemokines in humans. Thromb Haemost (2011) 106:353-62. doi:10.1160/TH11-01-0020
102. Liu CY, Battaglia M, Lee SH, Sun QH, Aster RH, Visentin GP. Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25-(nonregulatory) T cells. J Immunol (2005) 174:2680-6. doi:10.4049/jimmunol.174.5.2680
103. Shi G, Field DJ, Ko KA, Ture S, Srivastava K, Levy S, et al. Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. J Clin Invest (2014) 124:543-52. doi:10.1172/JCI71858
104. Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, RatliffTL. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol (2005) 78:80-4. doi:10.1189/jlb.1104669
105. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity (2003) 19:9-19. doi:10.1016/S1074-7613(03)00177-8
106. Danese S, de la Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol (2004) 172:2011-5. doi:10.4049/jimmunol.172.4.2011
107. Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med (2005) 11:1167-9. doi:10.1038/nm1317
108. Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol (2007) 46:719-26. doi:10.1016/j.jhep.2007.01.007
109. Loria GD, Romagnoli PA, Moseley NB, Rucavado A, Altman JD. Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood (2013) 121:940-50. doi:10.1182/blood-2011-08-376822
110. SchwartzkopffF, Grimm TA, Lankford CS, Fields K, Wang J, Brandt E, et al. Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication. Innate Immun (2009) 15:368-79. doi:10.1177/1753425909106171
111. Zaldivar MM, Pauels K, von Hundelshausen P, Berres ML, Schmitz P, Bornemann J, et al. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology (2010) 51:1345-53. doi:10.1002/hep.23435
112. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, et al. Lang, aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 14:756-61. doi:10.1038/nm1780
113. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 179(Suppl 1):S188-91. doi:10.1086/514283
114. Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet (2003) 362:1953-8. doi:10.1016/S0140-6736(03)15012-X
115. Cummins D, Fisher-Hoch SP, Walshe KJ, Mackie IJ, McCormick JB, Bennett D, et al. A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br J Haematol (1989) 72:543-8. doi:10.1111/j.1365-2141.1989.tb04321.x
116. Michels M, Alisjahbana B, De Groot PG, Indrati AR, Fijnheer R, Puspita M, et al. Platelet function alterations in dengue are associated with plasma leakage. Thromb Haemost (2014) 112:352-62. doi:10.1160/TH14-01-0056
117. Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, et al. In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest (2012) 141:1490-5. doi:10.1378/chest.11-2860
118. Bunce PE, High SM, NadjafiM, Stanley K, Liles WC, Christian MD. Pandemic H1N1 influenza infection and vascular thrombosis. Clin Infect Dis (2011) 52:e14-7. doi:10.1093/cid/ciq125
119. Starko KM. Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence. Clin Infect Dis (2009) 49:1405-10. doi:10.1086/606060
120. Tufano A, Di Capua M, Coppola A, Conca P, Cimino E, Cerbone AM, et al. The infectious burden in atherothrombosis. Semin Thromb Hemost (2012) 38:515-23. doi:10.1055/s-0032-1315759
121. Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost (2011) 106:858-67. doi:10.1160/TH11-06-0392
122. Haji SA, Starling RC, Avery RK, Mawhorter S, Tuzcu EM, Schoenhagen P, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant (2004) 23:277-83. doi:10.1016/S1053-2498(03)00148-7
123. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One (2011) 6:e16103. doi:10.1371/journal.pone.0016103
124. Vliegen I, Stassen F, Grauls G, Blok R, Bruggeman C. MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice. J Clin Virol (2002) 25(Suppl 2):S159-71. doi:10.1016/S1386-6532(02)00095-1
125. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis (2009) 9:601-10. doi:10.1016/S1473-3099(09)70233-6
126. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation (2003) 107:762-8. doi:10.1161/01.CIR.0000048190.68071.2B
127. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation (2001) 103:2283-8. doi:10.1161/01.CIR.103.18.2283
128. Damien P, Cognasse F, Lucht F, Suy F, Pozzetto B, Garraud O, et al. Highly active antiretroviral therapy alters inflammation linked to platelet cytokines in HIV-1-infected patients. J Infect Dis (2013) 208:868-70. doi:10.1093/infdis/jit260